X
19Dec

As its COVID-19 Vaccine Nears Finalization, AstraZeneca Announces Deal to Buy Alexion for $39 Billion

AstraZeneca, the British-Swedish multinational pharmaceutical company currently collaborating with the University of Oxford on a COVID-19 vaccine, will purchase Alexion Pharmaceuticals for $39 billion. The transaction, which awaits approval by shareholders and regulators, is the largest purchase by a health care company this year and is expected to close in the third quarter of 2021. Alexion was founded in 1992 and is headquartered in Boston but has a global presence. It is known for its...
By: Rothwell, Figg, Ernst & Manbeck, P.C.
Source Url: https://www.jdsupra.com/legalnews/as-its-covid-19-vaccine-nears-88769/

Related

Tips for conducting a year-end 401(k) plan review

According to the Internal Revenue Service (IRS), the best way for an employer to avoid 401(k) plan m...

Read More >

A Lesson for Employers: The Obligation to Pay H-1B Workers May Begin Even Before the H-1B Petition is Approved

An IT consulting company based in Southern California recently paid $48,193 to one employee after th...

Read More >

Time is Money…Except When It Isn’t - Financial Consequences of Extensions of Time in Construction Contracts

Time and money are often seen as going hand in hand in construction contracts. In a typical employer...

Read More >

Financial Daily Dose 10.28.2019 | Top Story: The EU gives Britain flexible 3-month Brexit extension

The EU has granted the UK another extension for the Brexit process, giving Britain until January 31 ...

Read More >

NLRB Restores 50+ Year-Old Precedent: Employers (Once Again) May Unilaterally Stop Deducting Union Dues Upon Contract Expiration

Mid-December is always a time where one can expect significant decisions to issue from the NLRB. In ...

Read More >

If Your Estate Plan Includes IRAs, a New Law Means It Is Time to Reevaluate

Both workers and retirees may need to rethink some of their estate planning in light of the newest s...

Read More >